GRB10 is a novel factor associated with gastric cancer proliferation and prognosis-Reference-Cited by-同舟云学术

GRB10 is a novel factor associated with gastric cancer proliferation and prognosis

Published:2023-03-23 Issue:9 Volume:15 Page:3394-3409
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Ren Li-Li¹,Wang Zhi-Wen²,Sen Ren³,Dai Zhou-Tong²⁴,Liao Xing-Hua²,Shen Li-Juan⁵

Affiliation:

1. School of Food and Drug, Shenzhen Polytechnic, Guangdong 518055, China

2. Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei 430081, China

3. Clinical Academy, Changsha Health Vocational College, Hunan 410100, China

4. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

5. Longgang District People's Hospital of Shenzhen, Guangdong 518172, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference39 articles.

1. Cancer Statistics, 2021.;Jemal;CA Cancer J Clin,2021

2. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.;Zhang;J Clin Lab Anal,2020

3. Clinical diagnostic values of transfer RNA-derived fragment tRF-19-3L7L73JD and its effects on the growth of gastric cancer cells.;Guo;J Cancer,2021

4. Cascades between miRNAs, lncRNAs and the NF-κB signaling pathway in gastric cancer (Review).;Wang;Exp Ther Med,2021

5. Gastric cancer diagnosis using hyperspectral imaging with principal component analysis and spectral angle mapper.;Yi;J Biomed Opt,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2/mTOR and Akt/c-Myc signaling pathway via GRB10;Hereditas;2024-09-02

2. Combination of Arsenic trioxide and Apatinib Synergistically Inhibits Small Cell Lung Cancer by Down-Regulating VEGFR2/mTOR and Akt/c-Myc Signaling Pathway via GRB10;2024-05-10